Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs (2004)
- Autores:
- Autores USP: COLQUHOUN, ALISON - ICB ; SILVA, DENISE DE OLIVEIRA - IQ
- Unidades: ICB; IQ
- Assunto: HISTOLOGIA
- Idioma: Inglês
- Imprenta:
- Local: São Carlos
- Data de publicação: 2004
- Fonte:
- Título do periódico: Program and Abstracts
- Nome do evento: Brazilian meeting on inorganic chemistry
-
ABNT
RIBEIRO, G. e COLQUHOUN, Alison e SILVA, Denise de Oliveira. Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs. 2004, Anais.. São Carlos: Instituto de Ciências Biomédicas, Universidade de São Paulo, 2004. . Acesso em: 24 abr. 2024. -
APA
Ribeiro, G., Colquhoun, A., & Silva, D. de O. (2004). Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs. In Program and Abstracts. São Carlos: Instituto de Ciências Biomédicas, Universidade de São Paulo. -
NLM
Ribeiro G, Colquhoun A, Silva D de O. Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs. Program and Abstracts. 2004 ;[citado 2024 abr. 24 ] -
Vancouver
Ribeiro G, Colquhoun A, Silva D de O. Synthesis and characterization of new diruthenium (II, III) complexes with non-steroidal anti-inflammatory drugs. Program and Abstracts. 2004 ;[citado 2024 abr. 24 ] - Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (NSAID) ibuprofen on the mRNA expression of proteins involved in cell cycle control, angiogenesis and invasion in C6 rat glioma cells in vitro
- Time-dependent effects of a novel ruthenium complex containing the non-steroidal anti-inflammatory drug (nsaid) ibuprofen on the mRNA expression of proteins involved in cell cycle control, Angiogenesis and Invasion in C6 rat glioma cells in vitro
- The novel ruthenium—γ-linolenic complex [Ru2(aGLA)4Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro
- Diruthenium(II,III)-non-steroidal anti-inflammatory drug complexes and their effects on tumor-cell proliferation
- Anti-tumour properties of novel ruthenium complexes containing non-steroidal anti-inflamatory drugs (NSAIDs)
- Inhibition of C6 rat glioma proliferation by ['RU IND. 2''CL''(ibp) IND. 4'] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential
- Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: synthesis, characterization and their effects on tumor-cell proliferation
- Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
- Diruthenium (II,III)-ketoprofen anticancer metallodrug investigated for interaction with transferrin and for effects on the antiproliferative activity, apoptotic and mitotic processes in the A172 human glioma cell line
- Growth inhibitory effects of the diruthenium-ibuprofen compound, 'RU IND. 2''CL'(Ibp)' IND. 4', in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
